Functional and Neurochemical Substrates of Chemotherapy-Related Cognitive Deficits
Investigating Cognitive Changes After Chemotherapy
Brief description of study.
Detailed description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: breast cancer
-
Age: 19 years - 55 years
-
Gender: Female
Able to complete and understand study questionnaires and procedures in English
Breast cancer survivors with a history of non-metastatic disease and chemotherapy treatment, between 6 months to five years post-chemotherapy completion
OR
Healthy
Exclusion Criteria
Any neurological or other medical disorder which may compromise subject safety or influence study outcomes (e.g., stroke, Parkinson's Disease, epilepsy, high blood pressure, diabetes, liver disease, cardiovascular disease, metastatic brain cancer, dementia)
Women who are pregnant, breast-feeding, or of childbearing potential and not using birth control
Current cigarette or marijuana smoking
Taking any medication in the past 30 days which could influence study outcomes (e.g. dopaminergic psychotropic medications or SNRIs)
Taking prescription opioid medication
Dependence on any drug other than caffeine or nicotine
Having no telephone or a reliable way in which study personnel can contact them
Subjects who are claustrophobic and cannot tolerate imaging procedures
Subjects who are contraindicated for magnetic resonance imaging (MRI) on standard IU screening forms: subjects who have metal implants, surgical devices, or other metal objects that would compromise the subject?s health during the MRI
Subjects who weigh > 350 lb. (upper weight limit of scanner beds)
The purpose of this study is to understand how chemotherapy affects brain function and brain chemistry. The study is looking at cognitive deficits, which means changes in memory and thinking skills, in breast cancer survivors compared to healthy women. This study investigates how these changes occur after chemotherapy treatment.
Participants will undergo screening procedures to confirm eligibility, which include answering questions and taking a pregnancy test. The study involves visits that may take about 4-5 hours, possibly spread over 2 days. Participants will be reimbursed $100 for their time and effort.
- Who can participate: Women who are breast cancer survivors, having completed chemotherapy 6 months to 5 years ago, or healthy women can participate. Participants should be able to understand and complete study procedures in English. Key exclusions include neurological disorders, pregnancy, smoking, and certain medication use.
- Study details: Participants will answer questions and undergo a pregnancy test to check eligibility. Participants will be paid $100 for their participation. A placebo is not involved in this study.